The authors concluded that daily interruption of sedation in mechanically ventilated critically-ill patients may be a promising treatment, but concerns about safety remain and further research is required. Although the authors' cautious conclusions appear to reflect the limited evidence, the limited search, poor reporting of review methods and lack of an adequate quality assessment undermine the robustness of the conclusions.
Results of the review
One randomised controlled trial (RCT; n=128) and two post-hoc analyses that included patients in the original trial were included in the review. The post-hoc analyses comprised a retrospective chart review (126 of the original patients) and a non-randomised comparison (32 patients who survived and were discharged: 18 patients from the original RCT and 14 non-randomised contemporaneous patients) of 13 patients in the intervention group versus 19 patients in a control group.
The RCT was single-blinded. The review authors stated that the baseline characteristics of the treatment groups were similar. Researchers who conducted the retrospective chart review were blinded and were not the original researchers. The non-randomised comparative analysis was conducted by researchers blinded to the treatment group.
The RCT reported that patients allocated to daily interruption of sedative required significantly fewer days of ventilation (4.9 versus 7.3 days, p<0.05), had significantly earlier discontinuation (p<0.05), spent significantly fewer days in the ICU (6.4 versus 9.9, p<0.05), and were awake for a greater percentage of days (85.5% versus 9%) compared with patients allocated to control. There was no difference between treatment groups in adverse events, need for reintubation or tracheostomy, hospital LOS, percentage of patients discharged home or mortality.
The retrospective chart review (n=126) reported that complications were significantly more common in the control group than in the intervention group (26 versus 13, p<0.05). Apart from gastrointestinal haemorrhage, specified complications (ventilator-associated pneumonia, bacteraemia, barotrauma requiring insertion of chest tube, venous thromboembolism, and cholestasis or sinusitis requiring surgery) were lower in the intervention group than in the control group, but the statistical significance of the difference was not reported.
The non-randomised comparison reported no statistically significant difference between patients in the intervention (n=13) and control (n=19) groups in various psychological measures.
Authors' conclusions
Daily interruption of sedation in mechanically ventilated critically-ill patients may be a promising treatment, but concerns remain about its safety and further research is required.
CRD commentary
The review addressed a clear question in terms of the participants and intervention. Inclusion criteria for the outcomes and study design were broad, which seems appropriate in view of the limited evidence identified. Limiting the search to one database and reference lists might have increased the potential for publication bias. The methods used to select studies and extract the data were not described, so it is not known whether any efforts were made to reduce reviewer error and bias. The validity assessment appears limited, thus the results from the included study and post-hoc analyses may not be reliable. In addition, since there was little information about the participants in the RCT, the generalisability of the results cannot be judged. Although the authors' cautious conclusions appear to reflect the evidence, the limited search, lack of reporting of review methods and lack of an adequate quality assessment undermine the robustness of the conclusions.
patients. The intervention should be evaluated using different analgesic and sedative agents (continuous infusion lorazepam, hydromorphone and fentanyl) and in other groups of patients (those under 40 years of age, surgical trauma ICU patients and patients with a history of alcohol or illicit drug abuse). Studies should assess acute withdrawal, measures of haemodynamic instability and pharmacoeconomic measures.
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